Aktie A2PRYX GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Guangzhou Kingmed Diagnostics Group Co., Ltd.

Aktien

A2PRYX

CNE100002VW1

603882

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 19.04.2024 		% 5 Tage % 1. Jan.
44.41 CNY -3.14% Intraday Chart für Guangzhou Kingmed Diagnostics Group Co., Ltd. -7.01% -29.02%
20.01. Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) gibt einen Aktienrückkauf im Wert von CNY 100 Millionen bekannt. CI
19.01. Guangzhou Kingmed Diagnostics Group Co., Ltd. genehmigt einen Rückkaufplan. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on January 20, 2024, has closed with 1,781,400 shares, representing 0.38% for CNY 99.99 million.
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on December 19, 2023, has closed with 1,696,800 shares, representing 0.36% for CNY 99.99 million.
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on December 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from SSE 180 Index
Guangzhou Kingmed Diagnostics Group Co., Ltd.(SHSE:603882) dropped from Shanghai Stock Exchange 180 Value Index
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.
Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 787,600 shares, representing 0.17% for CNY 49.99 million.
Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.
China's Small Hospitals, Clinics Banking on AI to Bridge Barriers in Diagnosis, Treatment
Kingmed Diagnostics to Repurchase Up to 50 Million Yuan Shares
Guangzhou Kingmed Diagnostics Group Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
Guangzhou Kingmed Diagnostics Group Co., Ltd. authorizes a Buyback Plan.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PRYX Aktie
  4. Nachrichten Guangzhou Kingmed Diagnostics Group Co., Ltd.
  5. Andere Sprachen